# Mark Galantowicz, MD – FDA Inspection, Feb 27, 2026

Source: https://www.keypedia.com/records/fda_inspections/mark-galantowicz-md/8ecbfc9c-a48e-41ef-8d3b-460006de9610
Source feed: FDA_Inspections

> FDA inspection 1306620 of Mark Galantowicz, MD, February 27, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1306620
- Company Name: Mark Galantowicz, MD
- Inspection Date: 2026-02-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/hugh-m-mcclure-iii/e69b7562-8fb5-4b7d-a506-a9bc0f0e9e43)

Company: https://www.keypedia.com/companies/mark-galantowicz-md/8c2f7d58-b539-4de8-89ac-7b0456039c04